Nuveen Asset Management, LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 122 filers reported holding KURA ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$6,662,553
-4.6%
730,543
+10.7%
0.00%0.0%
Q2 2023$6,982,355
+86390.2%
659,958
-0.0%
0.00%
-33.3%
Q1 2023$8,073
-6.5%
660,101
-5.1%
0.00%0.0%
Q4 2022$8,633
-99.8%
695,661
+104.4%
0.00%
+50.0%
Q3 2022$4,649,000
+12.1%
340,384
+50.4%
0.00%0.0%
Q2 2022$4,149,000
-50.3%
226,342
-56.9%
0.00%
-33.3%
Q1 2022$8,351,000
+32.6%
525,186
+16.7%
0.00%
+50.0%
Q4 2021$6,298,000
-28.4%
449,846
-4.2%
0.00%
-33.3%
Q3 2021$8,795,000
+12.8%
469,592
+25.6%
0.00%
+50.0%
Q2 2021$7,796,000
-4.9%
373,908
+29.0%
0.00%
-33.3%
Q1 2021$8,196,000
-65.7%
289,919
-60.4%
0.00%
-62.5%
Q4 2020$23,903,000
-6.8%
731,869
-12.6%
0.01%
-20.0%
Q3 2020$25,659,000
+99.8%
837,452
+6.3%
0.01%
+100.0%
Q2 2020$12,844,000
+233.3%
787,976
+103.4%
0.01%
+150.0%
Q1 2020$3,854,000
-8.9%
387,397
+25.9%
0.00%0.0%
Q4 2019$4,232,000
-27.3%
307,758
-19.8%
0.00%0.0%
Q3 2019$5,819,000
+205.0%
383,560
+295.9%
0.00%
+100.0%
Q2 2019$1,908,00096,8750.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2019
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders